MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1525.68%
Quick Ratio
1525.68%
Cash Ratio
1486.71%
Debt to Asset Ratio
6.53%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Prepaid and other current assets
    • Non-current prepaid expenses and...
    • Investment in marketable securit...
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accrued expenses
    • Others

Balance Sheets
2026-06-30
Cash and cash equivalents
22,925
Investment in marketable securities
0
Prepaid and other current assets
601
Total current assets
23,526
Property and equipment, net
78
Non-current prepaid expenses and other assets
0
Total non-current assets
78
Total assets
23,604
Trade payables
614
Accrued expenses
815
Employee-related obligations
113
Total current liabilities
1,542
Total liabilities
1,542
Additional paid-in capital
786,307
Accumulated other comprehensive income
0
Accumulated deficit
-764,245
Total stockholders' equity
22,062
Total liabilities and stockholders equity
23,604
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$22,925K Prepaid and othercurrent assets$601K Property and equipment,net$78K Total current assets$23,526K Total non-currentassets$78K Total assets$23,604K Total liabilities andstockholders equity$23,604K Total stockholders'equity$22,062K Total liabilities$1,542K Accumulated deficit-$764,245K Additional paid-in capital$786,307K Total currentliabilities$1,542K Accrued expenses$815K Trade payables$614K Employee-related obligations$113K

Yarrow Bioscience, Inc. (YARW)

Yarrow Bioscience, Inc. (YARW)